Trademark: 86955371
Word
ACCEL RESEARCH SITES
Status Date
Tuesday, April 3, 2018
Registration Number
5435841
Registration Date
Tuesday, April 3, 2018
Filing Date
Monday, March 28, 2016
Published for Opposition
Tuesday, January 16, 2018
35 Business consulting and management in the field of clinical trials in all phases as it relates to pre-study document collection and review, site selection, visits and audits, site compliance, project tracking and monitoring reports, negotiation and administration of investigator grants and clinical trial budgets and contracts, financial and management accounting, distribution, coordination and tracking of clinical trial products and materials, regulatory document processing, laboratory selection and coordination; Business consulting and management in the field of clinical trials in all phases as it relates to managing site and study-specific subject recruitment strategies and programs in the nature of contingency strategies and solutions to address specific project challenges; Business consulting and management in the field of clinical trials in all phases as it relates to managing the development of all study related documents and materials in the nature of study protocols, contracts, budgets, amendments, paper and electronic case report forms, informed consent forms, safety narratives, presentation posters, and training manuals; Business consulting and management in the field of clinical trials in all phases as it relates to managing all aspects of study, drug reconciliation, and inventory and distribution reports; Business management for all aspects of clinical trials in all phases as it relates to managing investigators, coordinators, monitors, technicians, and participants for compliance with clinical protocols and regulations; Business consulting and management in the field of clinical trials in all phases as it relates to management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials in all phases as it relates to ethical reviews, namely, submitting clinical trial protocols to institutional review boards and independent ethics committees on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical trials; Statistical analysis and reporting services for business purposes in the field of clinical trials; Business project management in the field of clinical trials in all phases as it relates to organizing and conducting business meetings of clinical trial investigators; Business management, namely, managing randomization logistics, in the pharmaceutical and biotechnological field for business purposes; Development and implementation of personnel recruitment and retention programs for investigators, coordinators, monitors, technicians and participants for use in clinical trials; Business consulting and management in the field of clinical trials in all phases as it relates to the administration of protocols involving volunteer research patients and the recruiting of such volunteer research patients; Providing data management services in the medical, pharmaceutical and biotechnological field for business purposes
45 Regulatory affairs, namely, reviewing standards and practices to assure compliance with clinical trial laws and regulations; Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research
42 Medical and scientific research consulting services for others in the field of design, planning, and implementation of clinical trials in all phases; providing quality assurance services in the pharmaceutical and biotechnological industries
Apr 3, 2024
Teas Section 8 Received
Jan 29, 2024
Teas Change Of Correspondence Received
Jan 29, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 29, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 29, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 29, 2024
Teas Change Of Owner Address Received
Apr 3, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Apr 3, 2018
Registered-Principal Register
Jan 16, 2018
Official Gazette Publication Confirmation E-Mailed
Jan 16, 2018
Published For Opposition
Dec 27, 2017
Notification Of Notice Of Publication E-Mailed
Dec 6, 2017
Assigned To Lie
Nov 28, 2017
Approved For Pub - Principal Register
Nov 9, 2017
Examiner's Amendment Entered
Nov 9, 2017
Notification Of Examiners Amendment E-Mailed
Nov 9, 2017
Examiners Amendment E-Mailed
Nov 9, 2017
Examiners Amendment -Written
Oct 23, 2017
Teas/Email Correspondence Entered
Oct 23, 2017
Correspondence Received In Law Office
Oct 23, 2017
Teas Response To Office Action Received
Oct 19, 2017
Notification Of Non-Final Action E-Mailed
Oct 19, 2017
Non-Final Action E-Mailed
Oct 19, 2017
Non-Final Action Written
Sep 28, 2017
Teas/Email Correspondence Entered
Sep 27, 2017
Correspondence Received In Law Office
Sep 27, 2017
Teas Response To Office Action Received
Aug 24, 2017
Notification Of Non-Final Action E-Mailed
Aug 24, 2017
Non-Final Action E-Mailed
Aug 24, 2017
Non-Final Action Written
Aug 2, 2017
Examiner's Amendment Entered
Aug 2, 2017
Notification Of Examiners Amendment E-Mailed
Aug 2, 2017
Examiners Amendment E-Mailed
Aug 2, 2017
Examiners Amendment -Written
Feb 6, 2017
Notification Of Non-Final Action E-Mailed
Feb 6, 2017
Non-Final Action E-Mailed
Feb 6, 2017
Non-Final Action Written
Jan 11, 2017
Teas/Email Correspondence Entered
Jan 11, 2017
Correspondence Received In Law Office
Jan 11, 2017
Teas Response To Office Action Received
Jul 15, 2016
Notification Of Non-Final Action E-Mailed
Jul 15, 2016
Non-Final Action E-Mailed
Jul 15, 2016
Non-Final Action Written
Jul 11, 2016
Assigned To Examiner
Mar 31, 2016
New Application Office Supplied Data Entered
Mar 31, 2016
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
